Potentia Pharmaceuticals Inc., a Louisville, Ky.-based drug startup focused on complement-related chronic inflammatory diseases such as AMD, has raised $12 million in new VC funding. HealthCare Ventures led the round, and was joined by return backer MASA Life Science Ventures.
PRESS RELEASE
Potentia Pharmaceuticals, Inc.,
Create an account to continue reading
Gain instant access to our expert editorial analysis and in-depth insight.
